Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
108.12
-8.34 (-7.16%)
At close: Jun 26, 2026, 4:00 PM EDT
107.90
-0.22 (-0.20%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Kymera Therapeutics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Kymera Therapeutics stock have an average target of 124.2, with a low estimate of 100 and a high estimate of 155. The average target predicts an increase of 14.87% from the current stock price of 108.12.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kymera Therapeutics stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 18 | 17 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 23 | 24 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Maintains $117 → $155 | Buy | Maintains | $117 → $155 | +43.36% | Jun 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $106 → $129 | Buy | Reiterates | $106 → $129 | +19.31% | Jun 26, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Reiterates $116 | Buy | Reiterates | $116 | +7.29% | Jun 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $123 → $119 | Buy | Maintains | $123 → $119 | +10.06% | Jun 26, 2026 |
| Citi | Citi | Buy Maintains $120 | Buy | Maintains | $120 | +10.99% | Jun 26, 2026 |
Financial Forecast
Revenue This Year
84.46M
from 39.21M
Increased by 115.40%
Revenue Next Year
41.02M
from 84.46M
Decreased by -51.44%
EPS This Year
-3.52
from -3.69
EPS Next Year
-4.35
from -3.52
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 124.0M | 97.5M | |
| Avg | 84.5M | 41.0M | |
| Low | 41.7M | -13.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 216.2% | 15.4% | |
| Avg | 115.4% | -51.4% | |
| Low | 6.3% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.64 | -3.21 | |
| Avg | -3.52 | -4.35 | |
| Low | -5.51 | -6.49 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.